-
About Company
Virat Lifesciences, a group company of Unital Formulations, Baddi, is setting up a state-of-the-art manufacturing facility for Sterile and Non-Sterile APIs at Lalru, Punjab. The company is led by Mr. Suresh Kumar Pathak with strategic consultation from Mr. Vivek Gupta, both having 14+ years of pharma industry experience.
-
Strong Legacy
Unital Formulations is a well-established pharma export unit producing injectables like Ceftriaxone, Meropenem, Heparin, Enoxaparin, and various SVP/LVP infusions including Paracetamol, Ofloxacin, Mannitol, Linezolid, and more.
-
Licencing & Compliance
VLS is FDA-licensed for sterile bulk drug manufacturing and adheres to cGMP (Schedule M), GLP (Schedule L–1), and WHO-GMP standards. All raw materials are sourced from certified international suppliers, with finished products exported via authorized local agents.
M/s Virat Life Sciences (VLS) has been floated to put up a Bulk Drugs (API’s) Sterile Sterile APIs and a plant for Oral API’s and Non- Sterile manufacturing unit at Village- Ranimajra, P.O. Lalru, Tehsil- Derabassi, Distt. Sahibzada Ajit Singh Nagar, Punjab.
Virat Life Sciences is a progressive pharmaceutical company specializing in the manufacturing and supply of bulk raw materials (APIs & intermediates). Founded under the leadership of Mr. Suresh Kumar Pathak (Proprietor) and supported by the vast expertise of Mr. Vivek Gupta, the company combines over 50 years of industry experience.
Mr. Suresh Kumar Pathak – 14+ years of rich experience in pharmaceutical manufacturing and business operations. Mr. Vivek Gupta – 40+ years of in-depth knowledge, strategy, and technical guidance in the pharmaceutical industry.
With state-of-the-art facilities, advanced technology, and a strong focus on compliance, we are committed to producing APIs that meet the highest global standards.
Virat Life Sciences has been granted with the licenses to manufacture selected sterile bulk drug products by the FDA, following a technical evaluation of the documents and the facilities. Licenses issued by the FDA are valid for a period of 5 years, after which they shall be duly subjected for renewal by abiding to the renewal guidelines. All the Pharmaceutical Manufacturing Activities shall be carryout in compliance with cGMP guidelines as specified under Schedule - M of the drugs and Cosmetic Act, 1940, GLP (Schedule L – 1) and WHO – GMP. The Raw materials which are being imported from country outside India shall be through registered traders/suppliers. Finished products to be exported in any country shall be through local agent of country with appropriate storage condition of material.